deoxycytidine has been researched along with Genome Instability in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Peña-Gómez, MJ; Rosado, IV; Suárez-Pizarro, M | 1 |
| Chen, ZN; Jiang, JL; Liu, Z; Tang, J; Yang, H; Zheng, M; Zhou, Y; Zhu, P | 1 |
| Atias, D; Berger, R; Borgida, A; Cuggia, A; Denroche, RE; Dodd, A; Fischer, SE; Gallinger, S; Glick, Y; Golan, T; Grant, RC; Halperin, S; Holter, S; Jang, GH; Knox, JJ; Notta, F; O'Kane, GM; Park, JP; Raitses-Gurevich, M; Renouf, DJ; Schaeffer, DF; Stossel, C; Wang, Y; Williamson, L; Wilson, JM; Wong, HL; Zhang, A; Zogopoulos, G | 1 |
| Algül, H; Azoitei, N; Bohnenberger, H; Frappart, PO; Gaedcke, J; Gieldon, L; Hampp, S; Hessmann, E; Hohwieler, M; Ihle, M; Kleger, A; Lechel, A; Lesina, M; Liebau, S; Lin, Q; Perkhofer, L; Reinhardt, HC; Romero Carrasco, MC; Ruess, DA; Russell, R; Schmitt, A; Schröck, E; Seufferlein, T; Sipos, B; Wagner, M; Wiesmüller, L | 1 |
| Bunimovich, YL; Cheng, D; McCracken, MN; McLaughlin, J; Nair-Gill, E; Radu, CG; Riedinger, M; Witte, ON | 1 |
| Abkevich, V; Carlson, RW; Chang, PJ; Dakhil, SR; Flaherty, PJ; Ford, JM; Goldstein, LJ; Haley, B; Hartman, AR; Head, B; Jensen, KC; Kurian, AW; Lipson, JA; Manola, J; Reid, JE; Schackmann, EA; Sparano, JA; Telli, ML; Timms, K; Vinayak, S; Wapnir, IL | 1 |
| Amato, NJ; Guerrero, CR; Gupta, S; Liu, S; Sharma, Y; Wang, Y; Yu, Y | 1 |
| Johnstone, E; Kerr, D; Midgley, R; Swanton, C; Tomlinson, I; Walther, A | 1 |
| Cabarcas, SM; Farrar, WL; Hurt, EM; Jaffee, EM; Mathews, LA; Zhang, X | 1 |
| Bellot, GL; Koh, D; Tan, WH; Tay, LL; Wang, X | 1 |
| Boettcher, M; Eisen, C; Fredebohm, J; Gaida, MM; Giese, NA; Greulich-Bode, KM; Heller, A; Hoheisel, JD; Hotz-Wagenblatt, A; Keleg, S; Lathrop, M; Tost, J | 1 |
2 review(s) available for deoxycytidine and Genome Instability
| Article | Year |
|---|---|
Genetic prognostic and predictive markers in colorectal cancer.
Topics: beta Catenin; Biomarkers, Tumor; Camptothecin; Capecitabine; Chromosomes, Human, Pair 18; Colorectal Neoplasms; Deoxycytidine; Fluorouracil; Gene Expression Profiling; Genes, APC; Genes, p53; Genomic Instability; Humans; Irinotecan; Microsatellite Instability; Mutation; Organoplatinum Compounds; Oxaliplatin; Pharmacogenetics; Prognosis; Proto-Oncogene Proteins; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins p21(ras); ras Proteins | 2009 |
Increased expression of DNA repair genes in invasive human pancreatic cancer cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Databases, Factual; Deoxycytidine; DNA Repair; DNA, Neoplasm; Gemcitabine; Gene Dosage; Gene Expression; Genes, BRCA1; Genomic Instability; Humans; Neoplasm Invasiveness; Neoplastic Stem Cells; Oligonucleotide Array Sequence Analysis; Pancreatic Neoplasms; Rad51 Recombinase; Spheroids, Cellular | 2011 |
1 trial(s) available for deoxycytidine and Genome Instability
| Article | Year |
|---|---|
Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Benzamides; BRCA1 Protein; BRCA2 Protein; Carboplatin; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Gene Expression Profiling; Genomic Instability; Humans; Mastectomy, Segmental; Middle Aged; Mutation; Neoadjuvant Therapy; Neoplasm Staging; Treatment Outcome; Triple Negative Breast Neoplasms | 2015 |
8 other study(ies) available for deoxycytidine and Genome Instability
| Article | Year |
|---|---|
XRCC1 Prevents Replication Fork Instability during Misincorporation of the DNA Demethylation Bases 5-Hydroxymethyl-2'-Deoxycytidine and 5-Hydroxymethyl-2'-Deoxyuridine.
Topics: 5-Methylcytosine; Cell Line; Cell Survival; Deoxycytidine; DNA Damage; DNA Demethylation; DNA Replication; Epigenesis, Genetic; Genomic Instability; Humans; Replication Origin; Thymidine; X-ray Repair Cross Complementing Protein 1 | 2022 |
CD147 promotes DNA damage response and gemcitabine resistance via targeting ATM/ATR/p53 and affects prognosis in pancreatic cancer.
Topics: Animals; Ataxia Telangiectasia Mutated Proteins; Basigin; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cytoplasm; Deoxycytidine; DNA Damage; Drug Resistance, Neoplasm; Gemcitabine; Genomic Instability; Humans; Mice; Pancreatic Neoplasms; Prognosis; Signal Transduction; Survival Analysis; Tumor Suppressor Protein p53 | 2020 |
Genomic Features and Classification of Homologous Recombination Deficient Pancreatic Ductal Adenocarcinoma.
Topics: Aged; Alleles; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Pancreatic Ductal; Cisplatin; Deoxycytidine; DNA-Binding Proteins; Drug Resistance, Neoplasm; Fanconi Anemia Complementation Group N Protein; Female; Fluorouracil; Gemcitabine; Genes, BRCA1; Genes, BRCA2; Genomic Instability; Germ-Line Mutation; Homologous Recombination; Humans; Irinotecan; Leucovorin; Male; Middle Aged; Oxaliplatin; Pancreatectomy; Pancreatic Neoplasms; Prognosis; Recombinational DNA Repair; Sensitivity and Specificity; Survival Rate; Tumor Suppressor Protein p53; Whole Genome Sequencing | 2021 |
ATM Deficiency Generating Genomic Instability Sensitizes Pancreatic Ductal Adenocarcinoma Cells to Therapy-Induced DNA Damage.
Topics: Animals; Ataxia Telangiectasia Mutated Proteins; Carcinoma, Pancreatic Ductal; Deoxycytidine; DNA Damage; Fluorouracil; Gemcitabine; Gene Expression; Genomic Instability; Humans; Immunohistochemistry; Male; Mice; Mice, SCID; Pancreatic Neoplasms; Phthalazines; Piperazines | 2017 |
Deoxycytidine kinase augments ATM-Mediated DNA repair and contributes to radiation resistance.
Topics: Animals; Ataxia Telangiectasia Mutated Proteins; B-Lymphocytes; Cell Line, Tumor; Deoxycytidine; Deoxycytidine Kinase; Deoxyribonucleosides; DNA Damage; DNA Repair; Genomic Instability; Hematopoiesis; Humans; Mice; Mice, Inbred BALB C; Mice, Knockout; Mutagenesis, Site-Directed; Phosphorylation; Protein Processing, Post-Translational; Substrate Specificity; T-Lymphocytes | 2014 |
Comprehensive Assessment of Oxidatively Induced Modifications of DNA in a Rat Model of Human Wilson's Disease.
Topics: Animals; Chromatography, Liquid; Copper; Deoxycytidine; Disease Models, Animal; DNA; Epigenesis, Genetic; Genomic Instability; Hepatolenticular Degeneration; Humans; Lipid Peroxidation; Liver; Nanotechnology; Oxidation-Reduction; Rats; Rats, Long-Evans; Reactive Oxygen Species; Spectrometry, Mass, Electrospray Ionization | 2016 |
Reliability of tumor primary cultures as a model for drug response prediction: expression profiles comparison of tissues versus primary cultures from colorectal cancer patients.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Cisplatin; Colorectal Neoplasms; Deoxycytidine; Down-Regulation; Doxorubicin; Etoposide; Floxuridine; Fluorescent Antibody Technique; Fluorouracil; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genomic Instability; Humans; Irinotecan; Metaphase; Paclitaxel; Polymerase Chain Reaction; Predictive Value of Tests; Protein Array Analysis; Reproducibility of Results; Tegafur; Tissue Array Analysis; Tumor Cells, Cultured; Up-Regulation; Uracil | 2012 |
Establishment and characterization of a highly tumourigenic and cancer stem cell enriched pancreatic cancer cell line as a well defined model system.
Topics: AC133 Antigen; Aldehyde Dehydrogenase 1 Family; Alleles; Animals; Antigens, CD; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Deoxycytidine; Disease Models, Animal; Drug Resistance, Neoplasm; Gemcitabine; Genomic Instability; Glycoproteins; GPI-Linked Proteins; Humans; Isoenzymes; Keratins; Male; Mesothelin; Mice; Middle Aged; Mutation; Neoplasm Metastasis; Neoplastic Stem Cells; Pancreatic Neoplasms; Peptides; Polyploidy; Retinal Dehydrogenase; Transplantation, Heterologous; Tumor Microenvironment | 2012 |